| HGNC Family | Solute carriers (SLC) |
| Name | solute carrier family 2 (facilitated glucose transporter), member 2 |
| Description | This gene encodes an integral plasma membrane glycoprotein of the liver, islet beta cells, intestine, and kidney epithelium. The encoded protein mediates facilitated bidirectional glucose transport. Because of its low affinity for glucose, it has been suggested as a glucose sensor. Mutations in this gene are associated with susceptibility to diseases, including Fanconi-Bickel syndrome and noninsulin-dependent diabetes mellitus (NIDDM). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC2A2 encodes the facilitative glucose transporter GLUT2, a low‐affinity, high‐capacity protein that plays a pivotal role in mediating bidirectional fluxes of glucose (and related sugars) across the plasma membranes of key metabolic tissues such as liver, kidney, and intestine. GLUT2 not only serves as the primary conduit for glucose reabsorption in the kidney and clearance in the liver but also functions as a glucose sensor—its cellular location and expression being tightly regulated by nutrient availability and transcription factors (for example, HNF‐1α) that coordinate its expression. In addition, studies have demonstrated that GLUT2 contributes to the transport of non‐glucose substrates such as glycerophosphoinositols and even dehydroascorbic acid, thereby influencing vitamin C bioavailability. Furthermore, its regulated translocation to specific membrane domains (for instance, the apical membrane in enterocytes under high‐glucose conditions) underlines the dynamic control of tissue‐specific glucose uptake. These observations underscore the importance of transcriptional control, post‐translational modifications and substrate interactions in determining GLUT2 function across tissues."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGenetic studies have repeatedly implicated SLC2A2 variants in the modulation of glycemic traits and type 2 diabetes risk. Common polymorphisms are associated with modest elevations in fasting plasma glucose and altered rates of progression from impaired glucose tolerance to overt diabetes, while certain rare mutations cause Fanconi–Bickel syndrome—a glycogen storage disorder with variable phenotypic severity. In addition, variant alleles have been linked to differences in dietary sugar preference and even to altered responsiveness to antidiabetic agents such as metformin, suggesting that liver GLUT2 expression (as evidenced by significant cis‐eQTL effects) is critical for drug action. Intriguingly, some associations extend to extra‐metabolic traits, including prostate cancer risk, thus broadening the clinical implications of SLC2A2 variation. Collectively, these genetic findings highlight the multifaceted consequences of altered GLUT2 activity on both metabolic homeostasis and disease susceptibility."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional functional analyses have further refined our understanding of GLUT2’s structure–function relationships. In vitro studies using engineered mutations and naturally occurring variants have revealed that even subtle alterations in protein structure can modify transport kinetics, influence membrane trafficking and ultimately affect insulin secretion and β‐cell differentiation. Complementary work investigating the SLC2A2 promoter has provided insights into gene‐specific regulation—even though some promoter variants appear not to alter disease risk. Moreover, GLUT2’s substrate specificity extends beyond glucose to include other molecules (such as dehydroascorbic acid), and investigations into its role in insulin receptor internalization have hinted at broader signaling interactions. Such studies, taken together with observations in cancer models (where altered GLUT2 expression may serve as a diagnostic or prognostic marker), underscore the clinical relevance of both its transport and sensor functions. These multifaceted investigations—including those into chromatin regulation and related protein interactions—highlight GLUT2 as a key determinant of cellular and whole‐organism metabolic homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "26", "end_ref": "34"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Nobuhiro Ban, Yuichiro Yamada, Yoshimichi Someya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatocyte nuclear factor-1alpha recruits the transcriptional co-activator p300 on the GLUT2 gene promoter."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/diabetes.51.5.1409"}], "href": "https://doi.org/10.2337/diabetes.51.5.1409"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11978637"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11978637"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Stefania Mariggiò, Cristiano Iurisci, Jordi Sebastià, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular characterization of a glycerophosphoinositol transporter in mammalian cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2006.11.039"}], "href": "https://doi.org/10.1016/j.febslet.2006.11.039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17141226"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17141226"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Helayne Soares Freitas, Beatriz D'Agord Schaan, Robinson Sabino da Silva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Insulin but not phlorizin treatment induces a transient increase in GLUT2 gene expression in the kidney of diabetic rats."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nephron Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000098442"}], "href": "https://doi.org/10.1159/000098442"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17204838"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17204838"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Seung-Soon Im, So-Youn Kim, Ha-il Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional regulation of glucose sensors in pancreatic beta cells and liver."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Diabetes Rev (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/157339906775473581"}], "href": "https://doi.org/10.2174/157339906775473581"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18220613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18220613"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Armelle Leturque, Edith Brot-Laroche, Maude Le Gall "}, {"type": "b", "children": [{"type": "t", "text": "GLUT2 mutations, translocation, and receptor function in diet sugar managing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Endocrinol Metab (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpendo.00004.2009"}], "href": "https://doi.org/10.1152/ajpendo.00004.2009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19223655"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19223655"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Susana Manzano, Gary Williamson "}, {"type": "b", "children": [{"type": "t", "text": "Polyphenols and phenolic acids from strawberry and apple decrease glucose uptake and transport by human intestinal Caco-2 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Nutr Food Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mnfr.201000019"}], "href": "https://doi.org/10.1002/mnfr.201000019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20564476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20564476"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Amal Ait-Omar, Milena Monteiro-Sepulveda, Christine Poitou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob/ob and high fat-fed mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db10-1740"}], "href": "https://doi.org/10.2337/db10-1740"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21852673"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21852673"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Ye Zheng, Jeffrey S Scow, Judith A Duenes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mechanisms of glucose uptake in intestinal cell lines: role of GLUT2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Surgery (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.surg.2011.07.010"}], "href": "https://doi.org/10.1016/j.surg.2011.07.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21943636"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21943636"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Christopher P Corpe, Peter Eck, Jin Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.436790"}], "href": "https://doi.org/10.1074/jbc.M112.436790"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23396969"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23396969"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Chiara Ghezzi, Donald D F Loo, Ernest M Wright "}, {"type": "b", "children": [{"type": "t", "text": "Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-018-4656-5"}], "href": "https://doi.org/10.1007/s00125-018-4656-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30132032"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30132032"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Laura J McCulloch, Martijn van de Bunt, Matthias Braun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: implications for understanding genetic association signals at this locus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Metab (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ymgme.2011.08.026"}], "href": "https://doi.org/10.1016/j.ymgme.2011.08.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21920790"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21920790"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "René Santer, Sebastian Groth, Martina Kinner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genet (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00439-001-0638-6"}], "href": "https://doi.org/10.1007/s00439-001-0638-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11810292"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11810292"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Inês Barroso, Jian'an Luan, Rita P S Middelberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Biol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pbio.0000020"}], "href": "https://doi.org/10.1371/journal.pbio.0000020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14551916"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14551916"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Cristen J Willer, Lori L Bonnycastle, Karen N Conneely, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Screening of 134 single nucleotide polymorphisms (SNPs) previously associated with type 2 diabetes replicates association with 12 SNPs in nine genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db06-0461"}], "href": "https://doi.org/10.2337/db06-0461"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17192490"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17192490"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Karen M Eny, Thomas M S Wolever, Bénédicte Fontaine-Bisson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Physiol Genomics (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/physiolgenomics.00148.2007"}], "href": "https://doi.org/10.1152/physiolgenomics.00148.2007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18349384"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18349384"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Josée Dupuis, Claudia Langenberg, Inga Prokopenko, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.520"}], "href": "https://doi.org/10.1038/ng.520"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20081858"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20081858"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Tamra E Meyer, Eric Boerwinkle, Alanna C Morrison, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-09-0902"}], "href": "https://doi.org/10.1158/1055-9965.EPI-09-0902"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20142250"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20142250"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "T W Boesgaard, N Grarup, T Jørgensen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated beta cell function in middle-aged Danish people."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-010-1753-5"}], "href": "https://doi.org/10.1007/s00125-010-1753-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20419449"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20419449"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Sarah Catharina Grünert, Karl Otfried Schwab, Martin Pohl, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fanconi-Bickel syndrome: GLUT2 mutations associated with a mild phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Metab (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ymgme.2011.11.200"}], "href": "https://doi.org/10.1016/j.ymgme.2011.11.200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22214819"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22214819"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "F H Sansbury, S E Flanagan, J A L Houghton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-012-2595-0"}], "href": "https://doi.org/10.1007/s00125-012-2595-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22660720"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22660720"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Lydie Izakovicova Holla, Petra Borilova Linhartova, Svetlana Lucanova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GLUT2 and TAS1R2 Polymorphisms and Susceptibility to Dental Caries."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Caries Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000430958"}], "href": "https://doi.org/10.1159/000430958"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26112465"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26112465"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Kaixin Zhou, Sook Wah Yee, Eric L Seiser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.3632"}], "href": "https://doi.org/10.1038/ng.3632"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27500523"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27500523"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Leszek Szablewski "}, {"type": "b", "children": [{"type": "t", "text": "Glucose Transporters in Brain: In Health and in Alzheimer's Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Alzheimers Dis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/JAD-160841"}], "href": "https://doi.org/10.3233/JAD-160841"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27858715"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27858715"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Osatohanmwen J Enogieru, Peter M U Ung, Sook Wah Yee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional and structural analysis of rare SLC2A2 variants associated with Fanconi-Bickel syndrome and metabolic traits."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.23758"}], "href": "https://doi.org/10.1002/humu.23758"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30950137"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30950137"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Yu Lei, Qiaoling Hu, Jiang Gu "}, {"type": "b", "children": [{"type": "t", "text": "Expressions of Carbohydrate Response Element Binding Protein and Glucose Transporters in Liver Cancer and Clinical Significance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Oncol Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12253-019-00708-y"}], "href": "https://doi.org/10.1007/s12253-019-00708-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31407220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31407220"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "A M Møller, N M Jensen, J Pildal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jcem.86.5.7499"}], "href": "https://doi.org/10.1210/jcem.86.5.7499"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11344224"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11344224"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "G C Banks, L J Deterding, K B Tomer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hormone-mediated dephosphorylation of specific histone H1 isoforms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M104641200"}], "href": "https://doi.org/10.1074/jbc.M104641200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11479299"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11479299"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Hansol Lee, Raymond Habas, Cory Abate-Shen "}, {"type": "b", "children": [{"type": "t", "text": "MSX1 cooperates with histone H1b for inhibition of transcription and myogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1098096"}], "href": "https://doi.org/10.1126/science.1098096"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15192231"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15192231"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Philippe Fonteyne, Veerle Casneuf, Patrick Pauwels, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histol Histopathol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14670/HH-24.971"}], "href": "https://doi.org/10.14670/HH-24.971"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19554504"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19554504"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "G V Kulkarni, T Chng, K M Eny, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of GLUT2 and TAS1R2 genotypes with risk for dental caries."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Caries Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000345652"}], "href": "https://doi.org/10.1159/000345652"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23257979"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23257979"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Aurélien Michau, Ghislaine Guillemain, Alexandra Grosfeld, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in SLC2A2 gene reveal hGLUT2 function in pancreatic β cell development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.469189"}], "href": "https://doi.org/10.1074/jbc.M113.469189"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23986439"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23986439"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Martial Boutchueng-Djidjou, Gabriel Collard-Simard, Suzanne Fortier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) plays a central role in insulin signaling and the Golgi/endosomes protein network."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Proteomics (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/mcp.M114.047159"}], "href": "https://doi.org/10.1074/mcp.M114.047159"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25687571"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25687571"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Emi Ono, Hiroyuki Murota, Yuki Mori, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sweat glucose and GLUT2 expression in atopic dermatitis: Implication for clinical manifestation and treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0195960"}], "href": "https://doi.org/10.1371/journal.pone.0195960"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29677207"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29677207"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Wolfgang Rathmann, Klaus Strassburger, Brenda Bongaerts, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-018-4759-z"}], "href": "https://doi.org/10.1007/s00125-018-4759-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30413829"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30413829"}]}]}]}
|
| Synonyms | GLUT2 |
| Proteins | GTR2_HUMAN |
| NCBI Gene ID | 6514 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SLC2A2 has 5,493 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 114 datasets.
Click the + buttons to view associations for SLC2A2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC2A2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC2A2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SLC2A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC2A2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SLC2A2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SLC2A2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SLC2A2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC2A2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC2A2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SLC2A2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC2A2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SLC2A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SLC2A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with SLC2A2 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with SLC2A2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC2A2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SLC2A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SLC2A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SLC2A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SLC2A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC2A2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SLC2A2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SLC2A2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SLC2A2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with SLC2A2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SLC2A2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with SLC2A2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SLC2A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SLC2A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SLC2A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SLC2A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for SLC2A2 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SLC2A2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC2A2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SLC2A2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SLC2A2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with SLC2A2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with SLC2A2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC2A2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SLC2A2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SLC2A2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SLC2A2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SLC2A2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SLC2A2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC2A2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SLC2A2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SLC2A2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding SLC2A2 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SLC2A2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SLC2A2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SLC2A2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SLC2A2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SLC2A2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SLC2A2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SLC2A2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SLC2A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SLC2A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding SLC2A2 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with SLC2A2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SLC2A2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SLC2A2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SLC2A2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC2A2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for SLC2A2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC2A2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SLC2A2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SLC2A2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with SLC2A2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for SLC2A2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SLC2A2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by SLC2A2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SLC2A2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SLC2A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SLC2A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SLC2A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate SLC2A2 protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways | pathways involving SLC2A2 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving SLC2A2 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC2A2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SLC2A2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SLC2A2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SLC2A2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SLC2A2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing SLC2A2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SLC2A2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SLC2A2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SLC2A2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SLC2A2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SLC2A2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SLC2A2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with SLC2A2 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SLC2A2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SLC2A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SLC2A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SLC2A2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SLC2A2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with SLC2A2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PID Pathways | pathways involving SLC2A2 protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving SLC2A2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving SLC2A2 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SLC2A2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SLC2A2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SLC2A2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SLC2A2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SLC2A2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SLC2A2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SLC2A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SLC2A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SLC2A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SLC2A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SLC2A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SLC2A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving SLC2A2 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SLC2A2 protein from the WikiPathways Pathways 2024 dataset. | |